Clinical trial
Novel Wound Powder RGN107 to Reduce Wound Odor, Pain and Exudate at End-of-life
NCT02008487 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Wound Powder RGN107 to Reduce Wound Odor, Pain and Exudate at End-of-life
- Lead sponsor
- Medical University of South Carolina
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- March 31, 2016
- Enrollment
- 50 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
pressure ulcer, wounds